Family · Pharmaceutical analytical standards
Asenapine
An atypical antipsychotic approved in the United States in 2009 for schizophrenia and for manic episodes of bipolar disorder. It was created by modifying the structure of mianserin, a tetracyclic antidepressant. This family brings together the active ingredient, metabolites, labelled standards and other impurities.
Did you know?It is taken as a tablet that dissolves under the tongue: if swallowed, less than 2% reaches the blood, compared with about 35% sublingually. A skin patch version came later.
No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
